These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 9712506)
1. Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantation. Faucher C; Fortanier C; Viens P; Le Corroller AG; Chabannon C; Camerlo J; Novakovitch G; Gastaut JA; Maraninchi D; Moatti JP; Blaise D Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S92-8. PubMed ID: 9712506 [TBL] [Abstract][Full Text] [Related]
2. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases]. Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932 [TBL] [Abstract][Full Text] [Related]
3. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells. Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF. Isola LM; Scigliano E; Skerrett D; Shank B; Ross V; Najfeld V; Fruchtman S Bone Marrow Transplant; 1997 Dec; 20(12):1033-7. PubMed ID: 9466275 [TBL] [Abstract][Full Text] [Related]
5. Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective. Couban S; Dranitsaris G; Andreou P; Price S; Tinker L; Foley R; Walker IR; Jamal S; Jamal N; Spaner D; Lipton J; Meharchand J; Messner HA Bone Marrow Transplant; 1998 Dec; 22(12):1199-205. PubMed ID: 9894724 [TBL] [Abstract][Full Text] [Related]
6. High dose therapy and autologous bone marrow versus blood cell rescue. South Island Bone Marrow Transplant Unit. Hill GR; Inder A; Patton WN; Hart DN N Z Med J; 1996 Feb; 109(1016):45-8. PubMed ID: 8598936 [TBL] [Abstract][Full Text] [Related]
7. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation. Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626 [TBL] [Abstract][Full Text] [Related]
8. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies. Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415 [TBL] [Abstract][Full Text] [Related]
9. [A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia]. Fan ZP; Yang K; Liu QF; Sun J; Xu D; Zhang Y; Wei YQ; Ye CX; Jiang QL; Meng FY Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1494-7, 1512. PubMed ID: 17062361 [TBL] [Abstract][Full Text] [Related]
10. Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC). Bredeson C; Malcolm J; Davis M; Bence-Bruckler I; Kearns B; Huebsch L Bone Marrow Transplant; 1997 Nov; 20(10):889-96. PubMed ID: 9404932 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and graft characteristics in pediatric matched sibling donor transplants using granulocyte colony-stimulating factor-primed bone marrow and steady-state bone marrow. Chiang KY; Haight A; Horan J; Olson E; Gartner A; Hartman D; Youssef S; Worthington-White D Pediatr Transplant; 2007 May; 11(3):279-85. PubMed ID: 17430483 [TBL] [Abstract][Full Text] [Related]
12. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse. Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738 [TBL] [Abstract][Full Text] [Related]
13. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation]. Sawada H; Wake A; Yamasaki Y; Izumi Y Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350 [TBL] [Abstract][Full Text] [Related]
14. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies. Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow. Nivison-Smith I; Bradstock KF; Szer J; Durrant S; Dodds A; Hermann R; Schwarer AP; Gibson J; To LB; Arthur C; Bone Marrow Transplant; 2001 Jul; 28(1):21-7. PubMed ID: 11498740 [TBL] [Abstract][Full Text] [Related]
16. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation. Lickliter JD; McGlave PB; DeFor TE; Miller JS; Ramsay NK; Verfaillie CM; Burns LJ; Wagner JE; Eastlund T; Dusenbery K; Weisdorf DJ Bone Marrow Transplant; 2000 Oct; 26(7):723-8. PubMed ID: 11042652 [TBL] [Abstract][Full Text] [Related]
17. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
18. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells. Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929 [TBL] [Abstract][Full Text] [Related]
19. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]